PulseExploreJournal ClubResearchersJournals
Instagram
HomeJournal ClubExplore
Synapse
⌘+K
Synapse
July 19, 2024Scientific ReportsOpen Access

Molecular dynamics-guided optimization of BGM0504 enhances dual-target agonism for combating diabetes and obesity

View Full Paper
Ask AI
Bookmark
Share

Authors

JYJiandong YuanWLWenlang LiuXJXiaohui Jiang

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Yuan et al. (2024) studied this question.

synapsesocial.com/papers/68e5fb6fb6db64358758f05fhttps://doi.org/10.1038/s41598-024-66998-8
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Design of a metabolically-stable peptide therapeutic with triple-hormone-receptor agonist activity2026
  2. 2Strategic Design of Triple GLP-1R/GCGR/GIPR Agonists with Varied Receptor Potency: Achieving Comparable Glycemic and Weight Reduction Effects2025 · 9 citations
  3. 3Engineered nutrient-stimulated hormonal multi-agonist for precision targeting of obesity and metabolic disorders2025 · 1 citations
  4. 4Computational assessment of the dimeric incretin GLP-1cpGLP-1 reveals the structural bases for its activity2025
  5. 5A trispecific GLP-1/anti-GIPR/FGF21 peptibody exhibits favorable metabolic effects in a diet-induced obesity model2026